A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection
N. Wittenbrink, S. Herrmann, A. Blazquez-Navarro, C. Bauer, E. Lindberg, P. Reinke, B. Sawitzki, O. Thomusch, C. Hugo, N. Babel, H. Seitz, M. Or-Guil
This paper develops a novel method using HLA class 1 single antigen bead signatures to predict acute cellular rejection risk pre-transplant with high accuracy.
bioRxiv · Oct 5, 2018Immunology